Biotech stocks advanced in the holiday-shortened week, with upside driven mainly by the broader market strength. Reflecting the extreme volatility in the space, a few stocks gyrated wildly in reaction …
More The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen’s Aducanumab Data And More Videos